0001172661-21-000387.txt : 20210212 0001172661-21-000387.hdr.sgml : 20210212 20210212162150 ACCESSION NUMBER: 0001172661-21-000387 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Rock Advisors, LP CENTRAL INDEX KEY: 0001540951 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14655 FILM NUMBER: 21627840 BUSINESS ADDRESS: STREET 1: 9 WEST 57TH STREET, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-993-7138 MAIL ADDRESS: STREET 1: 9 WEST 57TH STREET, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Summit Rock Advisors, LLC DATE OF NAME CHANGE: 20120131 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001540951 XXXXXXXX 12-31-2020 12-31-2020 false Summit Rock Advisors, LP
9 West 57th Street, 12th Floor New York NY 10019
13F HOLDINGS REPORT 028-14655 N
Emily Locher Chief Compliance Officer 212-993-7180 /s/ Emily Locher New York NY 02-12-2021 0 10 286745
INFORMATION TABLE 2 infotable.xml AKERO THERAPEUTICS INC COM 00973Y108 384 14891 SH SOLE 14891 0 0 GENERATION BIO CO COM 37148K100 258 9113 SH SOLE 9113 0 0 INVESCO EXCH TRADED FD TR II SR LN ETF 46138G508 10409 467191 SH SOLE 467191 0 0 ISHARES TR CONV BD ETF 46435G102 16631 172253 SH SOLE 172253 0 0 ISHARES TR CORE S&P US VLU 464287663 45175 726403 SH SOLE 726403 0 0 ISHARES TR IBOXX HI YD ETF 464288513 36181 414440 SH SOLE 414440 0 0 PHATHOM PHARMACEUTICALS INC COM 71722W107 1141 34350 SH SOLE 34350 0 0 VANGUARD INTL EQUITY INDEX F FTSE SMCAP ETF 922042718 59429 487765 SH SOLE 487765 0 0 VANGUARD INTL EQUITY INDEX F TT WRLD ST ETF 922042742 102246 1104408 SH SOLE 1104408 0 0 VANGUARD WORLD FD EXTENDED DUR 921910709 14891 97773 SH SOLE 97773 0 0